Norris Medicines has informed that the Board of Directors of the Company at its meeting held on Thursday, the 15th September, 2022 has granted its approval to make an application to Registrar of Companies for seeking extension of time to hold the Annual General Meeting for the financial year ended 31st March, 2022 by three months due to administrative reasons faced by the Company.
The above information is a part of company’s filings submitted to BSE.